Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約10-14 週間 | ¥ 452,500 |
50 mg | 約10-14 週間 | ¥ 590,000 |
100 mg | 約10-14 週間 | ¥ 893,000 |
説明 | LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors. |
分子量 | 603.55 |
分子式 | C29H32F2N3O7P |
CAS No. | 1258595-14-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1M NaOH: 50 mg/mL (82.84 mM), when pH is adjusted to 12 with NaOH. Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LHC-165 1258595-14-0 Immunology/Inflammation TLR LHC 165 LHC165 Inhibitor inhibitor inhibit